Curto-Barredo, L., Spertino, J., Figueras-Nart, I., -Serrano, E. , V, Guilabert, A., Melé-Ninot, G., … Giménez-Arnau, A. (2018). Omalizumab updosing allows disease activity control in refractory patients with chronic spontaneous urticaria. The British Journal of Dermatology. https://doi.org/10.1111/bjd.16379 (Original work published 2018)